Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Rankning i aktier #27064
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Aktiekurs
$2.04
Senast synkroniserad: 2025-12-09
Marknadsvärde
$35.38M
Förändring (1 dag)
0.00%
Förändring (1 år)
-2.39%
Land
IE
Handel Mural Oncology plc (MURA)

Kategori

Historik för aktiesplit för Mural Oncology plc (MURA)
Aktien Mural Oncology plc (symbol: MURA) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 20, 2026.
En MURA-aktie köpt före Aug 20, 2026 motsvarar nu 0 MURA-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH